| 发明名称 |
ANTINEOPLASTIC COMBINATIONS COMPRISING CCI-779 (RAPAMYCIN DERIVATIVE) TOGETHER WITH GEMCITABINE OR FLUOROURACIL |
| 摘要 |
<p>The invention provides the use of a combination of an mTOR inhibitor such as a rapamycin and an antimetabolite antineoplastic agent such as gemsitabine or fluorouracil in the treatment of neoplasms.</p> |
| 申请公布号 |
SI1385551(T1) |
申请公布日期 |
2008.12.31 |
| 申请号 |
SI20020030737T |
申请日期 |
2002.04.05 |
| 申请人 |
WYETH FIVE GIRALDA FARMS |
发明人 |
GIBBONS JAMES JOSEPH JR.;DUKART GARY;FRISCH JURGEN HERMANN ERNST |
| 分类号 |
A61K31/4353;A61K31/436;A61K31/4965;A61K31/513;A61K31/519;A61K31/7068;A61K45/06;A61P35/00;A61P35/02 |
主分类号 |
A61K31/4353 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
